RowDiagnosed 2026-10-11 21:23:14 KSTMMIRMAI Stock Diagnostic ReportMirum Pharmaceuticals to share phase 3 LIVMARLI study resultsMirum Pharmaceuticals announced plans to release Phase 3 study results for LIVMARLI, but as the actual results have not yet been disclosed, the outlook for the stock remains neutral.View Source Article ↗ AI CATALYST SCORE35 / 100Score computed by Sentinel V12REFERENCE PRICENot measuredReference entry price at analysis time 👍 0🔥 0🤔 0🔗 0𝕏f🔗📤